Multidisciplinary Assesssment of Structured Report for Cervical Cancer Staging
STRECC
1 other identifier
observational
30
1 country
1
Brief Summary
This study aims to validate a structured report for cervical cancer anchored to the FIGO staging system. A structured report is hypothesized to aid in uniformly applying FIGO staging, reducing staging discrepancies and improving patient care and outcomes. Furthermore, we believe that the participation of the clinicians will improve the quality of the report to minimize the need for multidisciplinary team discussion
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2024
CompletedFirst Posted
Study publicly available on registry
February 15, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedMarch 13, 2025
March 1, 2025
1.1 years
February 7, 2024
March 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy of a contextual structured report
Primary endpoint of the study is to assess referring physicians' (gynecologists and radiation oncologists) overall satisfaction rate with structured reports for staging MRI of patients with cervical cancer, in terms of overall response rate ≥4 at the first 5 items (i.e., an overall score ≥20)
1 year
Secondary Outcomes (3)
Satisfaction rate with narrative and structured report
1 year
Comparison Single items response rate, on both narrative and structured reports
1 year
Differences in the single 6-to-12 items response rate between structured and narrative reports.
1 year
Interventions
MRI examinations will be performed on 1.5T or 3T scanners, with protocol according to ESUR guidelines.The contextual structured report will be generated by the investigators in consensus. In every centre, one report (structured or narrative) will be generated from various radiologists experienced in gynaecologic imaging during clinical practice. Two radiologists in consensus, will develop the second version (narrative or structured report).
Eligibility Criteria
Patients with biopsy-proven cervical cancer (any FIGO stage) undergoing staging MRI afferent to the participating centers satisfying the following inclusion/exclusion criteria.
You may qualify if:
- Age ≥18 years old;
- Overt biopsy-proven diagnosis of cervical cancer, at any stage;
- Signed written informed consent to personal data treatment for research purposes
You may not qualify if:
- Age \<18 years old;
- Uncertain diagnosis of cervical cancer;
- MRI scan not according the standard acquisition protocol (ESUR guidelines);
- Patients candidate to non-standard treatments;
- Refusal to sign the written informed consent to personal data treatment for research purposes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Advanced Radiology Center
Rome, 00168, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Evis Sala, Prof
Fondazione Policlinico Universitario A. Gemelli, IRCCS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2024
First Posted
February 15, 2024
Study Start
March 1, 2024
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
March 13, 2025
Record last verified: 2025-03